Literature DB >> 19750067

Tackling partial response to depression treatment.

.   

Abstract

Entities:  

Year:  2009        PMID： 19750067      PMCID： PMC2736033          DOI： 10.4088/PCC.8133ah3c

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  49 in total

1.  Residual symptoms in depressed patients who respond acutely to fluoxetine.

Authors:  A A Nierenberg; B R Keefe; V C Leslie; J E Alpert; J A Pava; J J Worthington; J F Rosenbaum; M Fava
Journal:  J Clin Psychiatry       Date:  1999-04       Impact factor: 4.384

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 4.  Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Authors:  George I Papakostas; Maurizio Fava
Journal:  Eur Neuropsychopharmacol       Date:  2008-09-26       Impact factor: 4.600

5.  Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.

Authors:  Maurizio Fava; Michael E Thase; Charles DeBattista; Karl Doghramji; Sanjay Arora; Rod J Hughes
Journal:  Ann Clin Psychiatry       Date:  2007 Jul-Sep       Impact factor: 1.567

6.  Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.

Authors:  J Craig Nelson; Carolyn M Mazure; Peter I Jatlow; Malcolm B Bowers; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2004-02-01       Impact factor: 13.382

7.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

8.  Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Arun V Ravindran; Sidney H Kennedy; M Claire O'Donovan; Angelo Fallu; Fernando Camacho; Carin E Binder
Journal:  J Clin Psychiatry       Date:  2008-01       Impact factor: 4.384

9.  Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.

Authors:  R Aronson; H J Offman; R T Joffe; C D Naylor
Journal:  Arch Gen Psychiatry       Date:  1996-09

10.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Authors:  Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.